Answers are grounded in this paper and cite their sources.
The flow-through dissolution technique is a well-known approach from the early 1970s described for low-solubility BCS Class II and IV (1) active pharmaceutical ingredients (APIs) and their drug products. This tool is suitable for evaluating and comparing APIs and formulations and for exploring special issues related to new chemical entities. The flow-through dissolution equipment (FTDE) is used mainly for research and development studies, but pharmacopeias also make it possible to develop a method for routine analysis on FTDE, and researchers can achieve significant results even when only a few milligrams of a new chemical entity is available. Furthermore, the volume of dissolution medium required is at least four times less, which is an economic advantage. The aim of this article is to emphasize the potentials of the equipment during the discovery and preclinical/preformulation phases.
No takes yet. Share an insight, caveat, or question.
Venczel et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: